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Abstract
Background: A screening program provides a teachable moment for primary prevention such as encouraging
smoking cessation. However, little is known about the efficacy of smoking cessation intervention delivered to the
general population through a community-based screening program.
Methods: A quasi-experimental untreated control design with pre-test and post-test was conducted with 42
subjects receiving advice from physician and nurses (the PNA group), 39 receiving an informational leaflet (the
leaflet group), and 308 control subjects.
Results: The overall rate of reaching the action stage was 25 %, 5.7 %, and 7.8 in the PNA group, the leaflet group, and
the control group, respectively. In approximately 45–60 % of all participants, the stage remained unchanged. Such an
association between the intervention groups and stage changes was statistically significant (p = 0.02). The PNA group
was more likely to have the improvement of stage (forward transition toward action stage) than the control group
[adjusted odds ratio (aOR) = 2.27 (1.07–4.84)]. Deterioration (backward transition toward precontemplation) in the PNA
intervention group was 37 % lower than that in the control group [aOR = 0.63 (0.20–2.01)].
Conclusions: This study demonstrated that smoking cessation advice from physician and nurse is conducive to
smoking cessation, as shown by greater movement toward and less movement away from smoking cessation through
a community-based integrated screening platform.
Keywords: Community, Intervention, Smoking cessation, Transtheoretical model
Background
The efficacy of brief advice provided by health care profes-
sionals in smoking cessation program has been demon-
strated to detect a significant increase in the rate of
quitting by 66 % in comparison with no advice by polling
data from 17 trials [1]. In spite of the finding from the tri-
als, it would be more informative if a further study is
conducted to throw light on why and how it works by
assessing the dynamic changes of processes in relation to
smoking cessation based on the transtheoretical model
(TTM) [2]. Instead of treating smoking cessation as a di-
chotomous status (smoking and quitting), the TTM model
considers smoking cessation a complex and continuous
cyclic processes [3]. It describes and explains different
stages of behavior change and the process of change by
defining five specific stages: precontemplation, contempla-
tion, preparation, action, and maintenance) [4–9].
In addition to the choice of theoretical model, setting
for smoking cessation play an important role. The most
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common setting for delivery of smoking cessation advice
was the primary care setting, followed by hospital wards,
outpatient clinics, and industrial clinics [1]. Intervention
has been rarely designed to be delivered in a community
setting and targeted at the general population. With the
advent of population-based screening for cancers and
chronic diseases, it has been advised that screenings may
provide an opportunity for teaching smoking cessation
[10], including self-help information [11], physician re-
ferral for abnormal computed tomography findings [12],
and smoking cessation advice from physicians [13]. For
example, the smoking cessation programs have been
jointly conducted with those screening programs for
lung cancer [10–23] and also for cervical cancer [24, 25].
Following the model built in Keelung Community-
based Integrated Screening program [26–29], Nantou
County’s community-based integrated screening (CIS)
(see below) aimed to deliver out-reaching screen service
into communities for residents aged 20 years or over in
Nantou. It is therefore possible for using the CIS as the
platform for delivering a smoking cessation intervention
for the underlying population.
The aim of this study was to evaluate the effects of two
intervention strategies, advice on smoking cessation from
physician and nurses and a self-contained informative leaf-
let, on the transitions through smoking-cessation stages
(including forward transition toward the action stage and
the backward transition toward precontemplation) through
a community-based integrated screening program. Because
the smoking prevalence rates were 46.9 % for males and
4.6 % females in Taiwan, respectively [30], we only included
men subjects in the current analysis.
Methods
Study population
Subjects were selected from those who smoked and
attended a community-based integrated screening pro-
gram in Nantou, the central county in Taiwan, a multiple-
screening model that has been described in full elsewhere
[26–29]. In brief, the Health Bureau of Nantou County
developed a program following the Keelung community-
based integrated screening program (KCIS), which is
tailored for early detection of multiple diseases including
five cancers (breast cancer, cervical cancer, oral cancer,
and colorectal cancers, and hepatocellular carcinoma) and
three chronic diseases (type 2 diabetes, hyperlipidaemia,
and hypertension). The recruitment criterion was in light
of self-reported smoking status obtained from the ques-
tionnaire which was administrated by screening attendees
themselves at on-site screening. Because there were few
female smokers (2.6 % of smokers), study population were
limited to males only.
All participants provided individual written informed
consent during the uptake of screening asked their
permission to link their screening data to external data
such as national mortality for evaluating the survivorship
of each participant for research purpose only. The
current analysis had been approved by the local ethical
committee of Nantou Health Bureau. All procedures
met requirements mandated by the ethical guidelines for
research in Taiwan today, including no-harms to partici-
pants, informed contents, privacy consideration, no inter-
est conflict, prudent sample size calculation, and the
freedom to withdraw from study. The research project
was approved by local health authority to meet any ethical
requirement mandated by Taiwanese government.
Study design, intervention, and data-collection protocol
A quasi-experimental untreated control design with pre-
test and post-test was adopted. The intervention was re-
lated to smoking cessation. Pre-test and post-testing
were to measure the stage changes in smoking cessation
following the transtheoretical model. The selection of
intervention group and the control group is delineated
as follows. Ten out of thirteen towns/villages in Nantou
County were involved in the current smoking cessation
study. Three were excluded due to the consideration of
feasibility of local health manpower.
The smoking status was self-reported by a question-
naire. The question was ‘Do you have smoking habit
currently?’ the answer included (1) never smoke (2) quit-
ted and (3) smoke currently. Because the study popula-
tion were current smokers, the quitter was define as
those who had quit at follow-up telephone survey.
A total of 6,372 subjects (638 in intervention group
and 5,734 in the control group) attended the Nantou
Community-based Integrated Screening (NT-CIS) from
February to September 2003. According to screening
data, 103 smokers were identified in the intervention
area out of 638 participants, and the smoking rate of the
intervention group was 16.14 %. We provided screening
results for participants within 2 weeks after on-site
screening. The participants in the intervention area were
classified according to whether they came back to con-
sult with the screening report in person. Among the
male smokers, 40 smokers took screening report at
health station in person and received smoking cessation
advice from physician and nurses directly. This group
was defined as the ‘physician- and nurse-advised group’
(PNA group). Another 53 smokers who did not come
back to take screening report in person, defined as ‘the
leaflet group’, received smoking cessation advice, a smok-
ing cessation informational leaflet, and their screening
report by mail.
For intervention groups, PNA group received advice
from physician including (1) a brief summary on smok-
ing participant’s age, smoking history, and chronic dis-
ease history accrued from screening questionnaire, (2)
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biochemical examination results from on-site screening,
and (3) a formal documentation of audience on smoking
cessation signed by physician. The average time to persuade
participants to stop smoking through physician was 42 s.
Participants who were introduced by the advice of smoking
cessation upon recommendation by physician signature
were taken by public health nurse to assess the willingness
of stop smoking and the degree of addiction to smoking,
and provide relevant information on smoking cessation for
them. Those who failed to take the results of first stage of
screening were noticed by mail with recommendation on
smoking cessation and relevant information, harm of smok-
ing, and benefit of smoking cessation on health together
with the results of the first stage of screening.
In the control group, there were 5,734 participants
and 1,065 smokers. The smoking rate of the control
group was 18.57 %. We chose 390 male smokers
(approximately four times the number of study subjects
in the intervention groups) from the control group by
simple random sampling. This group, defined as ‘the
control group’, was still invited to undertake the routine
screening but none of any formal smoking cessation ad-
vice either from physician or nurse directly or from the
mailed leaflet was provided.
Public health nurses followed all three groups (namely
PNA, leaflet, and control groups) by telephone from
October to December 2003, approximately 2 to 8 months
after screening, to interview them in order to glean infor-
mation on smoking cessation stage. Figure 1 summarises
the procedure for implementing the current study
and collecting data. The details of procedure are
given in Additional file 1. The participant flow chart
is shown in Fig. 2.
According to our sample size, the statistical power
using multivariable logistic regression model was ap-
proximately 64.3 % for PNA group versus the control
group, and 54.3 % for the comparison of three groups
when the leaflet group (with the smallest sample size)
were added.
Instrument and definition of variables
Data sources for this study included screening data and
follow-up telephone survey data. Baseline variables from
the questionnaire included age (≤50, 51–64 or ≥65 years),
smoking commencement age (<20, ≥20 years), time of
first cigarette in the morning (<30 or ≥30 min after wak-
ing), smoking cessation advice from others in the previous
6 months (yes/no), and personal disease history (hyperten-
sion, diabetes).
The primary outcome variable was the change in smok-
ing cessation stage, as measured by the response to two
questions: ‘are you a current smoker?’ and ‘have you ever
seriously considered stopping smoking, and if so, when do
you plan to stop?’ Possible responses to the first question
were ‘yes’ and ‘no’. Responses to the second question in-
cluded ‘never’, ‘yes, but not sure when I will quit’, ‘yes, and I
intend to quit in the next 6 months’, ‘yes, and I intend to
quit within one month’, and ‘I have quit smoking’ (this re-
sponse was in the follow-up questionnaire only). Follow-
ing the transtheoretical model [6, 31, 32], the smoking
cessation stages at baseline were divided into three cat-
egories: precontemplation (smokers who have never con-
sidered quitting), contemplation (smokers who have
considered quitting), preparation (smokers who have con-
sidered quitting and intended to quit in the next 6 months
and this month). The smoking-cessation stage at follow-
Fig. 1 Implementation procedure and data collection in 2003
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up was categorized into one of four stages, precontempla-
tion, contemplation, preparation, and action (smokers
who had quit at follow-up).
The outcome variable was the change in smoking ces-
sation stage, which was classified in one of three cat-
egories at follow-up based on a comparison with the
stage at baseline: ‘improvement’, ‘deterioration’, and ‘no
change’. Improvements included the change from pre-
contemplation at baseline to contemplation, preparation,
or action at follow-up; the change from contemplation
at baseline to preparation or action at follow-up; and the
change from preparation at baseline to action at follow-
up. Deterioration included the change from contempla-
tion at baseline to precontemplation at follow-up and
the change from preparation at baseline to precontem-
plation or contemplation at follow-up. ‘No change’ re-
ferred to smokers whose stage at follow-up was the
same as that at baseline.
Statistical analysis
Descriptive statistics (frequency and percentage) were
used to describe the distribution of demographic and
smoking-related control variables. We used chi-square
and t-tests to examine differences between baseline in-
formation and intervention. The Fisher’s exact test was
used to examine differences between categories when
cell numbers are small. To assess the effects of interven-
tion on the changes in smoking-cessation stages given
the low number of participants, we defined three cat-
egories of stage change: improvement, deterioration, and
no change, as mentioned above. We used frequency and
percentage to show distribution of smoking cessation
stage at follow-up survey by stage at baseline and three
groups. Then, we used the chi-square test to examine
the relationships among the three categories of smoking
cessation stage change and related factors, which in-
cluded age, smoking commencement age, time of first
cigarette in the morning after waking, cessation advice
from others, and intervention group. Multinomial logis-
tic regression was conducted to estimate the interven-
tion effect after adjustment for other significant
variables. A significance level of 5 % was set for statis-
tical significance. All analyses were conducted using SAS
version 9.2.
Results
Descriptive results at baseline
Table 1 shows the frequencies of sociodemographic char-
acteristics, smoking-related behaviour, and history of
chronic disease at baseline among male smokers. There
were lacking of difference across three groups, PNA, leaf-
let, and control group with respect to smoking-related be-
haviours, as shown in Table 1. There were also lacking of
statistically significant differences across the three groups
with respect to diabetes, and hypertension.
Changes in smoking cessation stage
As shown in Table 2, smoking cessation stages at follow-up
were significantly associated with those at baseline. Add-
itionally, the changes in smoking cessation stage revealed
that a higher percent of those who were at the preparation
stage at baseline changed to the action stage in the follow-
up survey (30 %) compared with those who were at the pre-
contemplation (7.4 %) and contemplation (9.8 %) stages at
Fig. 2 Participant flow in quasi-experimental untreated control design with pre-test and post-test effectiveness of advice from physical and nurse
on smoking cessation stage
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baseline. The proportion of those in the action stage at
follow-up was higher in the PNA group (25 %) than in the
leaflet group (5.7 %) and the control group (7.8 %).
The relationship between the intervention and smok-
ing cessation stages before and after intervention were
examined. As shown in Table 2, of those who were in
the precontemplation category at baseline, the propor-
tion who took action was higher in the PNA group
(21.4 %) than in the leaflet (4.5 %) and the control
groups (5.5 %). Of those who were in preparation stage
at baseline, the proportion who took action was higher
in the PNA group (66.7 %) than in the control (25.0 %) and
leaflet groups (0.0 %). The absolute differences between the
PNA group and the control group in the percentage of par-
ticipants who moved from precontemplation, contempla-
tion, and preparation to action were 15.9, 13.4, and 41.7 %,
respectively.
The distribution of change as defined by three categories,
improvement (n = 102), deterioration (n = 73), and no
change (n = 183) with respect to age, smoking related fac-
tors at baseline, and intervention group, are shown in
Table 3. The results revealed that 28.5 % of male smokers
showed improvement in smoking stage, whereas 20.4 %
deteriorated. The changes in stage were significantly
Table 1 Distribution of socio-demographic, smoking related attributes, chronic disease, and biochemical markers among male smokersat
baseline. (N = 489)
variables Total % Intervention χ2 (degree of
freedomP&NA Group Leaflet Group Control
n % n % n % p value
489 46 9.4 53 10.8 390 79.8
Age Group
≦50 96 19.6 3 6.5 10 18.9 83 21.3 χ2(df=4) = 8.27
51–64 119 24.3 9 19.6 12 22.6 98 25.1 p = 0.08
≧65 274 56.0 34 73.9 31 58.5 209 53.6
Smoking related attributes
Smoking commence age
<20 121 26.0 14 33.3 12 23.1 95 25.7 χ2(df=4) = 3.52
20 156 33.5 15 35.7 14 26.9 127 34.3 p = 0.48
>20 188 40.4 14 33.3 26 50.0 148 40.0
NK 24 3 1 20
Time for first cigarette at morning
<30 min 286 60.7 29 64.4 34 68.0 223 59.3 χ2(df=2) = 1.69
≧30 min 185 39.3 16 35.6 16 32.0 153 40.7 p = 0.43
NK 18 1 3 14
Smoking cessation advice from others
yes 167 36.3 18 40.0 16 32.0 133 36.4 χ2(df=2) = 0.67
no 293 63.7 27 60.0 34 68.0 232 63.6 p = 0.72
NK 29 1 3 25
Smoking cessation stage at baseline
Precontemplation (PC) 285 61.0 33 73.3 34 66.7 218 58.8 χ2(df=4) = 5.96
Contemplation (C) 156 33.4 9 20.0 16 31.4 131 35.3 p = 0.20
Preparation (P) 26 5.6 3 6.7 1 2.0 22 5.9
NK 22 1 2 19
Chronic disease at baseline
Diabetes history 40 9.6 3 3.5 4 7.7 33 10.0 χ2(df=2) = 0.28(p = 0.87)
Hypertension history 67 15.8 9 10.6 3 5.8 55 16.4 χ2(df=2) = 4.39(p = 0.11)
precontemplation (PC): smokers who never consider to quit
contemplation (C): smokers who ever consider and intent to quit in the six months
preparation (P): smokers who ever consider and intent to quit in this month
NK not know
PNA Physician and nurse advice group
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associated with having received cessation advice from
others (p = 0.04) but were not statistically associated with
age of smoking commencement (p = 0.81) and time of the
first cigarette upon waking in the morning (p = 0.45). The
rate of improvement was considerably higher in the PNA
group than in the control group (45 % versus 25.8 %),
whereas the rate of deterioration was lower in the PNA
group (10 % versus 23.3 %). A similar but less remarkable
finding was noted for the leaflet group (see Table 3). Ap-
proximately 45–60 % of all participants were in the
category of no change. The association between interven-
tion group and the changes in stage was statistically signifi-
cant (p = 0.02).
Table 4 shows after adjusting for smoking cessation
advice from others, individuals in the PNA group were
more likely to show improvement than were those in the
control group [adjusted odds ratio (OR) = 2.27 (95 % CI:
1.07–4.84)], whereas the improvement in the leaflet
group was close to that in the control group [adjusted
OR =0.99 (95 % CI: 0.44–2.25)].
Table 2 Distribution of smoking cessation stage at follow-up survey by stage at baseline and intervention group (n = 358)
Precontemplation (PC): smokers who never consider to quit
Contemplation (C): smokers who ever consider and intent to quit in the six months
Preparation (P): smokers who ever consider and intent to quit in this month
NK not know
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The deterioration in the PNA group was 37 % lower
than that in the control group [adjusted OR = 0.63 (95 %
CI: 0.20–2.01)] (Table 4). The deterioration in the leaflet
group was 67 % lower [adjusted OR = 0.33 (95 % CI:
0.09–1.15)] than that in the control group (Table 4).
When the results for the two intervention groups were
combined, the decrease in deterioration was 54 %, al-
though the results failed to reach statistical significance
[adjusted OR = 0.46 (0.19–1.09)] (data not shown). It
is interesting to note that those who had received
cessation advice from others were more likely to show
deterioration than were those who had not received
such advice [adjusted OR = 2.21 (95 % CI: 1.14–4.29)];
however, the influence on improvement was not
statistically significant [adjusted OR = 1.05 (95 % CI:
0.62–1.78)].
Discussion
Applying the TTM model to smoking cessation program
implemented through an integrate screening platform,
we found the advice from physician and nurses (the
PNA group) could significantly enhance change toward
the action stage (forward transition) for quitting smok-
ing and reduce (albeit not statistically significantly) the
possibility of regressing to a stage farther from the ac-
tion stage (backward transition). The strategy provided
with only leaflet (the leaflet group) for participants could
not have such benefit. Of the smoking-related factors,
Table 3 Relationships between changes in smoking cessation stage and related factors (n = 358)
Variables n % Change of smoking cessation stage Chi-Square test Crude OR(95 % C.I.)




n % n % n %
358 183 51.1 73 20.4 102 28.5
Age group
≦50 65 18.2 31 47.7 16 24.6 18 27.7 χ2 = 1.58 1.00 1.00
51–64 90 25.1 46 51.1 20 22.2 24 26.7 p = 0.81 0.83 (0.37–1.88) 0.67 (0.28–1.58)
≧65 203 56.7 106 52.2 37 18.2 60 29.6 1.03 (0.51–2.07) 0.65 (0.31–1.36)
Smoking-related factors
Smoking commence age
<20 92 26.6 49 53.3 19 20.7 24 26.1 χ2 = 1.59 1.00 1.00
20 121 35.0 62 51.2 21 17.4 38 31.4 p = 0.81 1.23 (0.64–2.36) 0.72 (0.34–1.55)
>20 133 38.4 67 50.4 30 22.6 36 27.1 1.10 (0.57–2.11) 1.05 (0.52–2.12)
NK 12 5 3 4
First cigarette in the morning
<30 min 210 60.9 102 48.6 43 20.5 65 31.0 χ2 = 1.59 1.00 1.00
≧30 min 135 39.1 74 54.8 27 20.0 34 25.2 p = 0.45 0.71 (0.42–1.20) 0.80 (0.44–1.46)
NK 13 7 3 3
Cessation advice from others
no 121 35.6 69 57.0 15 12.4 37 30.6 χ2 = 6.49 1.00 1.00
yes 219 64.4 105 47.9 52 23.7 62 28.3 p = 0.04 1.06 (0.63–1.79) 2.19 (1.13–4.22)
NK 18 9 6
Intervention group
Control 283 79.1 144 50.9 66 23.3 73 25.8 χ2 = 11.20 1.00 1.00
PNA 40 11.2 18 45.0 4 10.0 18 45.0 p = 0.02 2.27 (1.07–4.83) 0.62 (0.20–1.95)
Leaflet 35 9.8 21 60.0 3 8.6 11 31.4 1.00 (0.44–2.26) 0.35 (0.10–1.22)
Precontemplation (PC): smokers who never consider to quit
Contemplation (C): smokers who ever consider and intent to quit in the six months
Preparation (P): smokers who ever consider and intent to quit in this month
Action (A): smokers who quit at follow-up
PNA group Physician and nurse advice group
aNo change’ means that the stage at follow-up was the same as that at baseline
bImprovement included: 1.from precontemplation at baseline to contemplation, preparation, and action at follow-up; 2. from contemplation to preparation and ac-
tion; 3. from preparation to action
cDeteriorate included: 1. from contemplation to Precontemplation; 2. from preparation to precontemplation and contemplation
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taking advice from others was conducive to regression
to a stage farther from the action stage, whereas its ef-
fect on movement toward the action stage was small.
Other smoking-related factors such as age of smoking
commencement and time of first cigarette after waking
in the morning did not statistically influence improve-
ment or deterioration in smoking cessation stage.
Effects of physician and nurse advice on the change in
smoking cessation stage
Our major intervention program was based on advice
from physician and nurses, as this is often regarded as a
potentially efficient approach [1]. Our main finding was
consistent with the results from systematic review that
concluded that physician advice and a good booster
from nurse’s consultation and advice for smokers to quit
will increase the rate of smoking cessation [1, 33–35].
However, as seen in previous studies, most physicians
have not routinely asked about their patients’ smoking
status [36, 37], and most smokers did not receive advice
to quit from their physician [38, 39]. Furthermore, a
large proportion of primary care physicians did not fol-
low recommendations to promote smoking cessation
among their patients [40]. The barriers to offering smok-
ing prevention counselling included lack of training in
smoking cessation [37], lack of patient educational mate-
rials, and lack of time [41]. On average, smokers were
less likely to have received advice to quit if they were
single (compared with divorced, widowed, or separated),
had higher levels of education, were lighter smokers, had
no previous quit attempts, and had physicians who
smoked [36]. It is timely to provide an easier and
quicker reminder method for physician to give smoking
cessation on smoking clients during screening process.
Our study designed a simple smoking cessation advice
form as a reminder to the physician.
Effects of informative leaflet distribution on smoking
cessation stage
We did not see a benefit of the intervention that entailed
distributing the self-contained informational leaflet in our
study, which was consistent with result from a previous
study [13]. Among current smokers who underwent low-
dose fast spiral chest CT for lung cancer screening, those
who received standard written self-help materials or a writ-
ten list of internet resources for smoking cessation showed
no statistically significant change in the 7-day point preva-
lence quit rates or advancement in motivational readiness
to stop smoking compared with the control [13].
The cyclic smoking cessation process using a
transtheoretical model
The proposed analysis method for our data is unique be-
cause we focused not only on stage changes from pre-
contemplation to action but also on changes in the
reverse direction, e.g., from preparation to precontem-
plation. Shedding light on these cyclic processes is
informative for understanding the factors that may ac-
count for stage changes indicating improvement, i.e.,
movement toward action, and deterioration, i.e., move-
ment away from action. Identifying both promoters and
inhibitors of smoking cessation gives clues for designing
an effective intervention program. Analysis of these cyc-
lic processes has not been considered in previous
screening-based intervention studies addressing changes
in smoking cessation stage [16, 22].
In our finding, in addition to forward transition, the
deterioration rates in the control group, i.e., movement
from preparation to contemplation or to precontempla-
tion, were considerably higher than those in the PNA
group (75.1 % versus 0 %). The deterioration rate from
contemplation to precontemplation was only slightly
higher in the control than in the PNA group (52.9 %
Table 4 Relationship between change in smoking cessation stage and intervention using multinominal logistic regression (n = 358)
Variables Change of smoking cessation stage
Improvementa / No changec Deteriorationb / No changec
OR 95 % CI OR 95 % CI
Cessation advice from others
No 1 1
Yes 1.05 0.62–1.78 2.21 1.14–4.29
Intervention group
Control 1 1
PNA 2.27 1.07–4.84 0.63 0.20–2.01
Leaflet 0.99 0.44–2.25 0.33 0.09–1.15
PNA Physician and nurse advice group
Independent variables included cessation advice from others and intervention group in the multinominal logistic regression
aImprovement included: 1.from precontemplation at baseline to contemplation, preparation, and action at follow-up; 2. from contemplation to preparation and ac-
tion; 3. from preparation to action
bDeterioration included: 1. from contemplation to Precontemplation; 2. from preparation to precontemplation and contemplation
c‘No change’ means that the stage at follow-up was the same as that at baseline
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versus 44.4 %), suggesting that smokers in the contem-
plation stage at baseline had the same chance of regres-
sing to precontemplation regardless of the intervention
group or the control group.
Our study found that those who had received cessation
advice from others were more likely to show deterioration
than were those who had not received such advice. Few
studies have been conducted to address why advice from
others showed an adverse effect for smoking cessation. It is
possible that advice from others in our study may contain
information that decrease the negative outcome expecta-
tions of smoking and the positive outcome expectations of
quitting. It requires a further study to clarify this cause.
Limitations and suggestions
There are pros and cons of the current study. Strength
of the current study are that the intervention program
in a community setting is relatively inexpensive and ac-
cessible to community residents. The weaknesses result-
ing from the expediency of this community-based study
is a lacking of randomized controlled study design and is
limited to the allocation of participants to two interven-
tions using other areas without intervention program as
the control group. However, as we have considered sev-
eral confounding factors, particularly smoking behav-
iours the results are supposed to be credible and
comparable to that if the randomized controlled trial de-
sign is adopted. As participants were not randomly
assigned to the intervention groups (PNA and informa-
tional leaflet) the group-assignment of participants in
our study to the PNA group or the leaflet group was
highly affected by depended on whether the participants
came back in person to receive the first-stage screening
report. Such an assignment may introduce bias, e.g. par-
ticipants who returned to take the screening in person
and were assigned to the PNA group may be more moti-
vated to stop smoking compared to participants who did
not return and were assigned to the leaflet group. How-
ever, we believe this concern may not be serious due to
the fact that there were lacking of statistical significance
differences across intervention groups with respect to
baseline characteristics. Admittedly, we have no informa-
tion about the maintenance of stage changes. The small
sample size of some groups may limit the results, particu-
larly in regard to deterioration in stage changes. As far as
statistical power is concerned, although the optimal ratio
of case to control group in term of cost and effect- size re-
lated to statistical power is 1 to 4, the ratio of case to the
control group increased to 1 to 9 in the current study may
increase cost but may not mitigate statistical power.
Conclusion
A community-based smoking cessation intervention
with a transtheoretical underpinning demonstrated that
advice on smoking cessation from physicians and nurses
is effective in smoking cessation, as evidenced by im-
provement in the stage of smoking cessation and a re-
duction in regression toward precontemplation.
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